Funding Details
- Awarder
- Inbox
- Date Award
- April 09, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$41,000,000
Company Info
- Founders
- Longwood Fund
- Company Description
- Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
- Market
- Cancer, Immunology, and other therapeutic areas
- Location
-
Boston,
MA,
USA
- Coinvestors
- Alexandria Venture Investments, Astellas Venture Management, Biovision Ventures, DCVC Bio, Eli Lilly and Company, Hengdian Group Capital, Longwood Fund, Pappas Capital, Sante Ventures, The Leukemia & Lymphoma Society
Links